Logo image of WGS

GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis

NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock - Currency: USD

66.635  -0.21 (-0.32%)

Fundamental Rating

4

WGS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. The financial health of WGS is average, but there are quite some concerns on its profitability. WGS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year WGS was profitable.
In the past year WGS has reported a negative cash flow from operations.
WGS had negative earnings in each of the past 5 years.
WGS had a negative operating cash flow in each of the past 5 years.
WGS Yearly Net Income VS EBIT VS OCF VS FCFWGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

The Return On Assets of WGS (-12.47%) is worse than 77.45% of its industry peers.
WGS's Return On Equity of -21.32% is on the low side compared to the rest of the industry. WGS is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
ROA -12.47%
ROE -21.32%
ROIC N/A
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
WGS Yearly ROA, ROE, ROICWGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K -5K

1.3 Margins

With an excellent Gross Margin value of 63.64%, WGS belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
In the last couple of years the Gross Margin of WGS has grown nicely.
WGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
WGS Yearly Profit, Operating, Gross MarginsWGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
WGS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WGS has more shares outstanding
Compared to 1 year ago, WGS has an improved debt to assets ratio.
WGS Yearly Shares OutstandingWGS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
WGS Yearly Total Debt VS Total AssetsWGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.01 indicates that WGS is not in any danger for bankruptcy at the moment.
WGS has a Altman-Z score of 3.01. This is in the better half of the industry: WGS outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that WGS is not too dependend on debt financing.
WGS has a Debt to Equity ratio of 0.29. This is in the better half of the industry: WGS outperforms 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 3.01
ROIC/WACCN/A
WACC8.77%
WGS Yearly LT Debt VS Equity VS FCFWGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

WGS has a Current Ratio of 3.61. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Current ratio of 3.61. This is amongst the best in the industry. WGS outperforms 91.18% of its industry peers.
WGS has a Quick Ratio of 3.42. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of WGS (3.42) is better than 90.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.61
Quick Ratio 3.42
WGS Yearly Current Assets VS Current LiabilitesWGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 124.14%, which is quite impressive.
WGS shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.79%.
WGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.26% yearly.
EPS 1Y (TTM)124.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.85%
Revenue 1Y (TTM)50.79%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%42.58%

3.2 Future

Based on estimates for the next years, WGS will show a very strong growth in Earnings Per Share. The EPS will grow by 133.79% on average per year.
The Revenue is expected to grow by 18.35% on average over the next years. This is quite good.
EPS Next Y308.39%
EPS Next 2Y190.18%
EPS Next 3Y133.79%
EPS Next 5YN/A
Revenue Next Year23.68%
Revenue Next 2Y21.02%
Revenue Next 3Y18.35%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WGS Yearly Revenue VS EstimatesWGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
WGS Yearly EPS VS EstimatesWGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30 -40

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

WGS is valuated quite expensively with a Price/Earnings ratio of 79.33.
WGS's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.88, WGS is valued quite expensively.
With a Price/Forward Earnings ratio of 34.41, WGS can be considered very expensive at the moment.
WGS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.20, WGS is valued quite expensively.
Industry RankSector Rank
PE 79.33
Fwd PE 34.41
WGS Price Earnings VS Forward Price EarningsWGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WGS Per share dataWGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WGS's earnings are expected to grow with 133.79% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y190.18%
EPS Next 3Y133.79%

More info and screens

0

5. Dividend

5.1 Amount

WGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENEDX HOLDINGS CORP

NASDAQ:WGS (5/1/2025, 2:58:08 PM)

66.635

-0.21 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-28 2025-07-28/amc
Inst Owners89.07%
Inst Owner Change-0.18%
Ins Owners1.7%
Ins Owner Change-3.22%
Market Cap1.90B
Analysts76
Price Target109.99 (65.06%)
Short Float %13.03%
Short Ratio3.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)198.09%
Min EPS beat(2)118.42%
Max EPS beat(2)277.76%
EPS beat(4)4
Avg EPS beat(4)128.54%
Min EPS beat(4)50.99%
Max EPS beat(4)277.76%
EPS beat(8)6
Avg EPS beat(8)65.6%
EPS beat(12)8
Avg EPS beat(12)38.3%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)16.14%
Min Revenue beat(2)15.16%
Max Revenue beat(2)17.12%
Revenue beat(4)4
Avg Revenue beat(4)18.08%
Min Revenue beat(4)15.16%
Max Revenue beat(4)22.31%
Revenue beat(8)8
Avg Revenue beat(8)11.15%
Revenue beat(12)10
Avg Revenue beat(12)3.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.47%
PT rev (3m)33.4%
EPS NQ rev (1m)-32.35%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-2.11%
EPS NY rev (3m)89.8%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)2.15%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)6.19%
Valuation
Industry RankSector Rank
PE 79.33
Fwd PE 34.41
P/S 6.22
P/FCF N/A
P/OCF N/A
P/B 7.75
P/tB 21.94
EV/EBITDA N/A
EPS(TTM)0.84
EY1.26%
EPS(NY)1.94
Fwd EY2.91%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS10.71
BVpS8.6
TBVpS3.04
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.47%
ROE -21.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.64%
FCFM N/A
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.01%
Cap/Sales 1.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.61
Quick Ratio 3.42
Altman-Z 3.01
F-Score6
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)124.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.85%
EPS Next Y308.39%
EPS Next 2Y190.18%
EPS Next 3Y133.79%
EPS Next 5YN/A
Revenue 1Y (TTM)50.79%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%42.58%
Revenue Next Year23.68%
Revenue Next 2Y21.02%
Revenue Next 3Y18.35%
Revenue Next 5YN/A
EBIT growth 1Y86.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year453.53%
EBIT Next 3Y130.44%
EBIT Next 5YN/A
FCF growth 1Y81.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.18%
OCF growth 3YN/A
OCF growth 5YN/A